| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | 0.45 | 0.004 |
| mRNA | RAF265 | FIMM | pan-cancer | AAC | 0.46 | 0.004 |
| mRNA | PI-103 | GDSC1000 | pan-cancer | AAC | -0.088 | 0.004 |
| mRNA | selumetinib:tretinoin (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | -0.094 | 0.005 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | -0.084 | 0.005 |
| mRNA | NSC23766 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | marinopyrrole A | CTRPv2 | pan-cancer | AAC | 0.12 | 0.005 |
| mRNA | temsirolimus | FIMM | pan-cancer | AAC | 0.42 | 0.005 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.15 | 0.005 |